May 8, 2026

Bioventus Inc. (BVS) Stock Analysis: Unpacking a 38.97% Potential Upside in the Medical Devices Sector

For investors keen on the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a captivating opportunity within the medical devices industry. This Durham, North Carolina-based company is..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Evaluating a Biotech with a 61% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention within the biotechnology sector, not just for its innovative approach to treating diseases with unmet medical needs but..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Navigating Growth Amidst a -0.14% Potential Downside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is a burgeoning player in the biotechnology sector, focusing on developing innovative treatments for pediatric and adult diseases. With a..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Promising 88% Upside in Healthcare Genomics

Personalis, Inc. (NASDAQ: PSNL), a pivotal player in the healthcare sector specializing in diagnostics and research, offers a compelling opportunity for investors intrigued by the burgeoning..

PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations

PureTech Health plc (PRTC), a dynamic player in the biotechnology industry, is making waves with its innovative pipeline despite facing financial challenges. As a company based..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 234% Potential Upside

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at revolutionizing cancer treatment. Headquartered in..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a Focus on Talent Management Services

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare sector, primarily operates within the medical care facilities industry in the United States. With..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 166.97% Potential Upside in Biotech Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands out as a compelling opportunity within the biotechnology sector, offering a remarkable potential upside of 166.97%. With a market capitalization of..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 128.92% Upside in the Biotech Sector

For investors seeking opportunities in the high-stakes world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing proposition. With a current market capitalization of $1.48 billion,..

Embecta Corp. (EMBC) Stock Analysis: A High Dividend Yield and Potential Upside of 122.22%

Embecta Corp. (NASDAQ: EMBC) presents an intriguing opportunity for investors, particularly those with a keen eye for high-yield dividends and significant potential upside. Operating in the..

Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring a Potential 121% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering entity in the healthcare sector, is drawing investor attention with its innovative approach to medical devices, particularly in..

EyePoint, Inc. (EYPT) Stock Analysis: A Biotech Gem with 177% Potential Upside

EyePoint, Inc. (EYPT), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating serious retinal diseases. With a market capitalization..

Auna SA (AUNA) Stock Analysis: Exploring a 43% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a key player in the healthcare sector, is garnering significant attention from investors due to its substantial upside potential and strategic positioning in..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a Promising 128% Upside Potential

COMPASS Pathways Plc (NASDAQ: CMPS) has been capturing investor attention with its pioneering approach in the mental health sector. Based in London, the company is making..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: 47.87% Potential Upside in the Biotech Arena

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the attention of investors with its promising potential upside of 47.87%, despite its current challenges. As a clinical-stage biotechnology..

Inventiva S.A. (IVA) Stock Analysis: Unpacking the 190% Upside Potential in Biotech’s Bold Bet

Inventiva S.A. (IVA), a French biopharmaceutical innovator, presents a compelling investment opportunity within the healthcare sector, specifically in the biotechnology industry. Known for its development of..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and Strategic Collaborations Point to Promising Future

Investors with a keen eye on the biotechnology sector might find Theravance Biopharma, Inc. (NASDAQ: TBPH) an intriguing prospect. As a company focused on developing and..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Potential 77% Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a pioneering company in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 77.77%. As a..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 77% Potential Upside Amidst Market Challenges

Tilray Brands, Inc. (NASDAQ: TLRY), a major player in the healthcare sector, specifically in the drug manufacturing industry, is navigating a complex landscape with its diversified..

Search

Funds

May 8, 2026

Search

Funds

May 8, 2026

FTSE 100

Funds